Malingering in ADHD and the use of symptom validity tests in neuropsychological assessment.

Completed

• Conditions: Malingering; suboptimal effort; 10009841

• Registration Number: NL-OMON32942
• Lead Sponsor: GGZ regio Breda (Breda)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

- Age 18-50
- Classified with ADHD according DSM IV
- No objection to pass one dosage of methylfenidate
- Permission of responsible medicist to skip one dosage of methylfenidate

Exclusion Criteria

- Not Dutch-speaking
- Usage of psychotrope medication or neuroleptica
- Comorbidity wit Psychotic Disorders or Bipolar Disorder. Exclusion criteria confirmed by responsible medicist.
- Comorbidity with major depression. Excluded by administration of a depression questionnaire.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Sensitivity en specificity of symptom validity tests for clinical use by<br /><br>patients with ADHD.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Malingerparameters on regular neuropsychological tests</p><br>